Jinyu Bio-technology Co., Ltd.

SHSE:600201 Stock Report

Market Cap: CN¥8.0b

Jinyu Bio-technology Future Growth

Future criteria checks 5/6

Jinyu Bio-technology is forecast to grow earnings and revenue by 43% and 23.3% per annum respectively. EPS is expected to grow by 38% per annum. Return on equity is forecast to be 7.4% in 3 years.

Key information

43.0%

Earnings growth rate

38.0%

EPS growth rate

Biotechs earnings growth42.4%
Revenue growth rate23.3%
Future return on equity7.4%
Analyst coverage

Low

Last updated22 Nov 2024

Recent future growth updates

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Sep 02
Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Recent updates

The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Sep 04
The Consensus EPS Estimates For Jinyu Bio-technology Co., Ltd. (SHSE:600201) Just Fell Dramatically

Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Sep 02
Revenue Miss: Jinyu Bio-technology Co., Ltd. Fell 9.1% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models

Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Jun 16
Why We're Not Concerned Yet About Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) 25% Share Price Plunge

Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

Apr 30
Jinyu Bio-technology Co., Ltd. (SHSE:600201) Analysts Are Reducing Their Forecasts For This Year

There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Mar 21
There's Reason For Concern Over Jinyu Bio-technology Co., Ltd.'s (SHSE:600201) Price

Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Feb 28
Does This Valuation Of Jinyu Bio-technology Co., Ltd. (SHSE:600201) Imply Investors Are Overpaying?

Earnings and Revenue Growth Forecasts

SHSE:600201 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20262,292505N/A6513
12/31/20251,926388N/A4455
12/31/20241,540283N/A4683
9/30/20241,350165148331N/A
6/30/20241,525272157405N/A
3/31/20241,582283223496N/A
12/31/20231,598284142415N/A
9/30/20231,639289221429N/A
6/30/20231,572240280445N/A
3/31/20231,551236151331N/A
12/31/20221,529211155345N/A
9/30/20221,546174233486N/A
6/30/20221,578229188493N/A
3/31/20221,599252124484N/A
12/31/20211,776382160533N/A
9/30/20211,813529245554N/A
6/30/20211,798482379673N/A
3/31/20211,735467446677N/A
12/31/20201,582406471700N/A
9/30/20201,387268415684N/A
6/30/20201,240234209481N/A
3/31/20201,159213239526N/A
12/31/20191,12722198405N/A
9/30/20191,312322-13349N/A
6/30/20191,646565-63408N/A
3/31/20191,673617-221293N/A
12/31/20181,897754-123422N/A
9/30/20182,008869196636N/A
6/30/20181,909842N/A713N/A
3/31/20181,997900N/A840N/A
12/31/20171,901870N/A945N/A
9/30/20171,809842N/A935N/A
6/30/20171,651748N/A910N/A
3/31/20171,635719N/A824N/A
12/31/20161,517645N/A756N/A
9/30/20161,393561N/A764N/A
6/30/20161,309518N/A588N/A
3/31/20161,252505N/A583N/A
12/31/20151,247480N/A494N/A
9/30/20151,210499N/A389N/A
6/30/20151,116436N/A501N/A
3/31/20151,063433N/A460N/A
12/31/20141,063404N/A585N/A
9/30/2014921346N/A837N/A
6/30/2014874308N/A785N/A
3/31/2014849277N/A809N/A
12/31/2013671251N/A649N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 600201's forecast earnings growth (43% per year) is above the savings rate (2.8%).

Earnings vs Market: 600201's earnings (43% per year) are forecast to grow faster than the CN market (25.5% per year).

High Growth Earnings: 600201's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 600201's revenue (23.3% per year) is forecast to grow faster than the CN market (13.7% per year).

High Growth Revenue: 600201's revenue (23.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 600201's Return on Equity is forecast to be low in 3 years time (7.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/30 11:30
End of Day Share Price 2024/12/30 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jinyu Bio-technology Co., Ltd. is covered by 22 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Jia ChenChangjiang Securities Co. LTD.
Fu YangChasing Securities